The historical rank and industry rank for Luyan Pharma Co's Gross Margin % or its related term are showing as below:
SZSE:002788'
s Gross Margin % Range Over the Past 10 Years
Min: 7.57 Med: 7.81 Max: 8.52
Current: 7.57
During the past 13 years, the highestGross Margin % of Luyan Pharma Co was 8.52%. The lowest was 7.57%. And the median was 7.81%.
SZSE:002788's Gross Margin % is ranked worse than 95.27% of 613
companies
in the Healthcare Providers & Services industry
Industry Median: 41.53
vs SZSE:002788: 7.57
Luyan Pharma Co had a gross margin of 7.36% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Luyan Pharma Co was -0.50% per year.
Luyan Pharma Co Gross Margin % Historical Data
The historical data trend for Luyan Pharma Co's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Luyan Pharma Co's Gross Margin %
For the Pharmaceutical Retailers subindustry, Luyan Pharma Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Luyan Pharma Co's Gross Margin % Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Luyan Pharma Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Luyan Pharma Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Luyan Pharma Co (SZSE:002788) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Luyan Pharma Co had a gross margin of 7.36% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Luyan Pharma Co Gross Margin % Related Terms
Thank you for viewing the detailed overview of Luyan Pharma Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Luyan Pharma Co (SZSE:002788) Business Description
Luyan Pharma Co Ltd, formerly Luyan (Fujian) Pharma Co Ltd engages in the production, operation, distribution, and retail of human health products in China. It provides medical and health products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:002788 has been successfully added to your 